UCSF

ZINC00137884

Substance Information

In ZINC since Heavy atoms Benign functionality
September 27th, 2005 16 Yes

Other Names:

vudine

1-(2,3-dideoxy-a-D-glycero-pent-2-enofuranosyl)thymine

1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI); 2',3'-Didehydro-3'-deoxythymidine; 2'-Thymidinene, 3'-deoxy-; 3'-Deoxy-2',3'-didehydrothymidine; BMY 27857; BMY-27857; BRN 0618327; C10H14N2O4; D 4T; D4T

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; 3'-Deoxy-2'-thymidinene; STV

1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione

1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione

1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2

132425-31-1

2',3' Didehydro 3' deoxythymidine

2',3'-Anhydrothymidine

2',3'-Anhydrothymidine; CPD000058350; SAM001246729; stavudine

2',3'-Didehydro-2',3'-dideoxythmidine

2',3'-Didehydro-3'-deoxythimidine

2',3'-Didehydro-3'-deoxythimidine; 3056-17-5; C07312; Sanilvudine; Stavudine; d4T

2',3'-Didehydro-3'-deoxythimidine;3'-Deoxy-2'-thymidinene;Estavudina [INN-Spanish];Sanilvudine;Stavudine [Usan:Ban:Inn];Stavudinum [INN-Latin];STV

2',3'-Didehydro-3'-deoxythymidine

2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI)

2'-Thymidinene, 3'-deoxy-

2,3-Didehydro-3-deoxythymidine

2กไ,3กไ-Didehydro-3กไ-deoxythymidine

3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor

3'-Deoxy-2',3'-didehydrothymidine

3'-Deoxy-2',3'-didehydrothymidine, 98%

3'-Deoxy-2'-thymidinene

3056-17-5

3056-17-5; D00445; Sanilvudine (JAN); Stavudine (USAN/INN); Zerit (TN)

AC-5263

AC1L2BQ9

AC1Q6BSH

BAN

BB_NC-1008

BIDD:GT0082

BMY 27857

BMY-27857

BMY-27857, Sanilvudine, NSC 163661

BMY-27857; D4T

BMY27857

Bristol-Myers Brand of Stavudine

Bristol-Myers Squibb Brand of Stavudine

BRN 0618327

C07312

CHEBI:207119

CHEBI:9253

CHEMBL991

CID18283

CPD000058350

CPD000058350; SAM001246729; STAVUDINE

CPD000058350; STAVUDINE

CPD000673569

CPD000673569; SAM002589948; STAVUDINE

D 1413

D 4T

D 4T (nucleoside)

D00445

D018119

D1413_SIGMA

D3580

d4T

D4T & GM-CSF

D4TMBY-27857-3

DAP000172

DB00649

ddeThd

ddeTyd

Dideoxydidehydrothymidine

DTH

Estavudina

Estavudina [INN-Spanish]

estavudina; stavudine; stavudinum

EU-0100336

FDA

FT-0082665

HMS2051O20

HSDB 7338

INN

LAMIVUDINE; LAMIVUDINE; STAVUDINE; LS-187991; STAVUDINE

LAMIVUDINE; LS-188039; STAVUDINE; STAVUDINE/LAMIVUDINE

LS-1160

MFCD00132921

MLS000028546

MLS000759504

MLS001055348

MLS001077292

MolPort-002-507-283

NA

NCGC00023212-03

NCGC00023212-04

NCGC00023212-05

NCGC00023212-07

NCGC00023212-08

NCGC00023212-09

NCGC00023212-10

NSC 163661

NSC163661

Octadecanoyl chloride

SAM001246729

SAM002589948

Sanilvudine

Sanilvudine (JAN)

SMR000058350

SMR000673569

SS-1664

Stavudine

Stavudine (BAN

Stavudine (d4T)

Stavudine (FDA

Stavudine (sodium)

Stavudine (USAN/INN)

Stavudine (USP

Stavudine [Usan:Ban:Inn]

Stavudine [USAN:INN:BAN]

Stavudine, Monosodium Salt

Stavudinum

Stavudinum [INN-Latin]

Stearoyl chloride

Stearoyl chloride, 98%+

STK801888

STV

Thymidine, 2',3'-didehydro-, 3'-deoxy-

Thymidine, 2',3'-didehydro-3'-deoxy-

Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI)

UNII-BO9LE4QFZF

USAN

USAN)

USP)

Zent

Zerit

Zerit (TN)

Zerit xr

Zerit(TM)

Zerut XR

ZINC00137884

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.54 -0.44 -16.04 2 6 0 84 224.216 2

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 4.05e+01 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 98% Matrix Scientific
Purity 98.5% APIChem
Therapy antiviral SMDC Pharmakon
H phrase H341: Suspected of causing genetic defects; H335: May cause respiratory irritation; H319: Causes serious eye irritation; H315: Causes skin irritation Acros Organics
Indications HIV KeyOrganics Bioactives
Warnings IRRITANT Matrix Scientific
Warnings Irritant/Refrigerate Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : S-1314; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE CRYSTALLINE POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP1625s NIH Clinical Collection via PubChem
P phrase P302 + P352: IF ON SKIN: Wash with plenty of soap and water; P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing; P304 + P340: IF INHALED: Remove to fresh air Acros Organics
UniProt Database Links POL_HV190; POL_HV192; POL_HV193; POL_HV196; POL_HV197; POL_HV19N; POL_HV1A2; POL_HV1AN; POL_HV1B1; POL_HV1B5; POL_HV1B9; POL_HV1BR; POL_HV1EL; POL_HV1ET; POL_HV1H2; POL_HV1JR; POL_HV1LW; POL_HV1M2; POL_HV1MA; POL_HV1MN; POL_HV1MP; POL_HV1MV; POL_HV1N5; PO ChEBI
R phrase R36/37/38: Irritating to eyes, respiratory system and skin.; R68: Possible risks of irreversible effects. Acros Organics
Target Reverse Transcriptase Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: S-1314; SUPPLIER_COMMENTS: WHITE CRYSTALLINE POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP1625s NIH Clinical Collection via PubChem
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
Z102020-1-O Porcine Endogenous Retrovirus (cluster #1 Of 1), Other Other 7800 0.45 Functional ≤ 10μM
Z50607-1-O Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other Other 651 0.54 Functional ≤ 10μM
Z50607-1-O Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other Other 940 0.53 Functional ≤ 10μM
Z50612-1-O Moloney Murine Sarcoma Virus (cluster #1 Of 2), Other Other 2500 0.49 Functional ≤ 10μM
Z50658-1-O Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other Other 790 0.53 Functional ≤ 10μM
Z50677-1-O Human Immunodeficiency Virus (cluster #1 Of 3), Other Other 770 0.53 Functional ≤ 10μM
Z80052-1-O C8166 (Leukemic T-cells) (cluster #1 Of 3), Other Other 80 0.62 Functional ≤ 10μM
Z80071-1-O CEM-0 (T-cell Leukemia) (cluster #1 Of 2), Other Other 800 0.53 Functional ≤ 10μM
Z80073-1-O CEM-c113 (cluster #1 Of 1), Other Other 80 0.62 Functional ≤ 10μM
Z80076-1-O CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other Other 59 0.63 Functional ≤ 10μM
Z80077-1-O CEM-TK(-) (cluster #1 Of 1), Other Other 10000 0.44 Functional ≤ 10μM
Z80294-1-O MT2 (Lymphocytes) (cluster #1 Of 1), Other Other 2000 0.50 Functional ≤ 10μM
Z80295-2-O MT4 (Lymphocytes) (cluster #2 Of 8), Other Other 710 0.54 Functional ≤ 10μM
Z80295-2-O MT4 (Lymphocytes) (cluster #2 Of 8), Other Other 770 0.53 Functional ≤ 10μM
Z80874-1-O CEM (T-cell Leukemia) (cluster #1 Of 7), Other Other 90 0.62 Functional ≤ 10μM
Z80874-1-O CEM (T-cell Leukemia) (cluster #1 Of 7), Other Other 270 0.57 Functional ≤ 10μM
Q72547-1-V Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral Viruses 500 0.55 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Q72547_9HIV1 Q72547 Human Immunodeficiency Virus Type 1 Reverse Transcriptase, 9hiv1 450 0.56 Binding ≤ 1μM
Q72547_9HIV1 Q72547 Human Immunodeficiency Virus Type 1 Reverse Transcriptase, 9hiv1 450 0.56 Binding ≤ 10μM
Z80052 Z80052 C8166 (Leukemic T-cells) 80 0.62 Functional ≤ 10μM
Z80874 Z80874 CEM (T-cell Leukemia) 160 0.59 Functional ≤ 10μM
Z80071 Z80071 CEM-0 (T-cell Leukemia) 1200 0.52 Functional ≤ 10μM
Z80073 Z80073 CEM-c113 10000 0.44 Functional ≤ 10μM
Z80076 Z80076 CEM-SS (T-cell Leukemia) 59 0.63 Functional ≤ 10μM
Z80077 Z80077 CEM-TK(-) 10000 0.44 Functional ≤ 10μM
Z50677 Z50677 Human Immunodeficiency Virus 770 0.53 Functional ≤ 10μM
Z50607 Z50607 Human Immunodeficiency Virus 1 2000 0.50 Functional ≤ 10μM
Z50658 Z50658 Human Immunodeficiency Virus 2 100 0.61 Functional ≤ 10μM
Z50612 Z50612 Moloney Murine Sarcoma Virus 2500 0.49 Functional ≤ 10μM
Z80294 Z80294 MT2 (Lymphocytes) 1800 0.50 Functional ≤ 10μM
Z80295 Z80295 MT4 (Lymphocytes) 18 0.68 Functional ≤ 10μM
Z102020 Z102020 Porcine Endogenous Retrovirus 7800 0.45 Functional ≤ 10μM

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.